M. Maes

发表

Cognitive features of amnestic Mild Cognitive Impairment using specific Cambridge Neuropsychological Test Automated Battery test scores

S. Hemrungrojn, C. Tunvirachaisakul, G. Nantachai, 2022, medRxiv.

Construction of a short version of the Montreal Cognitive Assessment (MoCA) rating scale using Partial Least Squares analysis

S. Hemrungrojn, A. Amrapala, M. Maes, 2022, medRxiv.

The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with peripheral inflammation, insulin resistance and lowered calcium

H. Al-Hakeim, A. Almulla, M. Maes, 2022, medRxiv.

Lowered quality of life in Long COVID is strongly predicted by affective symptoms and chronic fatigue syndrome which are associated with inflammatory processes during the acute infectious phase and consequent neuroimmunotoxic pathways.

M. Kubera, Michael Maes, H. Al-Hakeim, 2022, medRxiv.

Antenatal depressive symptoms are strongly predicted by the severity of pre-menstrual syndrome: results of partial least squares analysis

M. Maes, J. Suwimonteerabutr, S. Satthapisit, 2022, medRxiv.

Paraoxonase 1 status is a major Janus-faced component of mild and moderate acute ischemic stroke and consequent disabilities

D. Barbosa, Michael Maes, F. F. Brinholi, 2022, Metabolic Brain Disease.

The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis

G. Oxenkrug, Michael Maes, H. Al-Hakeim, 2022, medRxiv.

Increased lipid peroxidation and lowered lipid-associated antioxidant defenses mediate the effects of the paraoxonase 1 (PON1) Q192R polymorphism on disabilities and final stroke core volume in mild and moderate stroke.

D. Barbosa, Michael Maes, F. F. Brinholi, 2022, medRxiv.

The negative symptoms of schizophrenia: lessons from a precision nomothetic psychiatry approach

M. Maes, 2022, medRxiv.

Research and Diagnostic Algorithmic Rules (RADAR) for mood disorders, recurrence of illness, suicidal behaviors, and the patients lifetime trajectory

S. Nunes, H. Vargas, Juliana Brum Moraes, 2022, medRxiv.

Research and Diagnostic Algorithmic Rules (RADAR) and RADAR Plots for the First Episode of Major Depressive Disorder: Effects of Childhood and Recent Adverse Experiences on Suicidal Behaviors, Neurocognition and Phenome Features

Michael Maes, A. Almulla, M. Maes, 2022, medRxiv.

Cerebral hemodynamics response to dual-task paradigms in older adults: A systematic review and meta-analysis

S. Hemrungrojn, G. Nantachai, M. Maes, 2022, medRxiv.

Modified sensory encoding during auditory hallucinations: case report and proposed mechanisms

B. van Sweden, M. Maes, H. Bryon, 2001, Acta Neuropsychiatrica.

Increased AGE-RAGE axis stress in methamphetamine (MA) abuse and MA-induced psychosis: associations with oxidative stress and increased atherogenicity

S. Moustafa, H. Al-Hakeim, A. Almulla, 2023, medRxiv.

Frontal cortex reactivity differentiates between schizophrenic subtypes: auditory ERP-evidence

B. Sweden, M. Maes, F. Mesotten, 2001, Acta Neuropsychiatrica.

In end-stage kidney disease, inflammation, erythron abnormalities and declined kidney function tests are accompanied by increased affective symptoms, chronic-fatigue, and fibromyalgia.

Michael Maes, S. Moustafa, H. Al-Hakeim, 2023, medRxiv.

The effects of adverse childhood experiences on depression and suicidal behaviors are partially mediated by neuroticism, a forme fruste of major depression.

K. Jirakran, A. Vasupanrajit, C. Tunvirachaisakul, 2023, medRxiv.

Towards a major methodological shift in depression research by assessing continuous scores of recurrence of illness, lifetime and current suicidal behaviors and phenome features: focus on atherogenicity and adverse childhood experiences

Michael Maes, K. Jirakran, A. Vasupanrajit, 2023, medRxiv.

Major depression, suicidal behaviors and neuroticism are pro-atherogenic states driven by lowered reverse cholesterol transport.

M. Kubera, K. Jirakran, A. Vasupanrajit, 2023, medRxiv.

Adverse childhood trauma and reoccurrence of illness impact the gut microbiome, which affects suicidal behaviors and the phenome of major depression: towards enterotypic-phenotypes

K. Plaimas, A. Suratanee, S. Payungporn, 2023, medRxiv.

Mood Symptoms and Chronic Fatigue Syndrome Due to Relapsing-Remitting Multiple Sclerosis Are Associated with Immune Activation and Aberrations in the Erythron

Michael Maes, H. Al-Hakeim, A. Almulla, 2022, medRxiv.

Brooding and neuroticism are strongly interrelated manifestations of the phenome of depression

K. Jirakran, A. Vasupanrajit, C. Tunvirachaisakul, 2023, medRxiv.

The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta‐analysis

A. Almulla, C. Tunvirachaisakul, M. Maes, 2023, medRxiv.

Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway

S. Moustafa, H. Al-Hakeim, A. Almulla, 2023, medRxiv.

Poly unsaturated fatty acids: the missing link between cardiac events and depression?

M. Maes, A. Honig, A. Honig, 2001, Acta Neuropsychiatrica.

Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviors: effects of in vitro cannabidiol administration.

A. Sughondhabirom, Michael Maes, K. Jirakran, 2023, medRxiv.

Effects of recurrence of illness and adverse childhood experiences on effector, cytotoxic, and regulatory T cells, and cannabinoid receptor-bearing B cells in major depression, an autoimmune disorder.

A. Sughondhabirom, K. Jirakran, M. Rachayon, 2023, medRxiv.

Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease.

S. Moustafa, H. Al-Hakeim, M. Maes, 2023, medRxiv.

T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviors

Michael Maes, H. Al-Hakeim, A. Almulla, 2023, medRxiv.

Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis

Michael Maes, H. Al-Hakeim, A. Almulla, 2023, Brain, Behavior, and Immunity.

Methamphetamine (MA) use, MA dependence, and MA-induced psychosis are associated with increasing aberrations in the compensatory immunoregulatory system and interleukin-1Î± and CCL5 levels

S. Sirivichayakul, R. Kalayasiri, M. Maes, 2023, medRxiv.

T cell activation via the CD40 ligand and transferrin receptor and deficits in T regulatory cells are associated with major depressive disorder and severity of depression

A. Sughondhabirom, K. Jirakran, M. Rachayon, 2023, medRxiv.

Adverse childhood experiences and recent negative events activate immune and growth factor pathways, which are associated with first episode major depression and suicidal behaviours

A. Almulla, M. Maes, A. A. Abo Algon, 2023, medRxiv.

Neuropsychiatric disturbances in mild cognitive impairment: A scientometric analysis

M. Solmi, M. Maes, Arisara Amrapala, 2023, Ageing Research Reviews.